List of hormonal cytostatic antineoplastic agents - Wikipedia
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind,...
Antineoplastic Agents, Hormonal / therapeutic use* * Aromatase Inhibitors / therapeutic use* * Breast Neoplasms / prevention & ...
Mortality impact of less-than-standard therapy in older breast cancer patients
ESR2 | Cancer Genetics Web
Antineoplastic Agents, Hormonal. *Genotype. *Genetic Predisposition. *Lung Cancer. *Tumor Burden. *Estrogen Receptors ... Effects of 60 kDa prolactin and estradiol on metabolism and cell survival in cervical cancer: Co‑expression of their hormonal ... The co‑expression of these receptors demonstrated the hormonal dependence of UCC. In addition, E2 and the 60 kDa PRL ... The present study aimed to evaluate the expression of hormonal receptors in different degrees of cervical lesions, and to ...
Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) Medication: Corticosteroids, Pulmonary, Tyrosine...
Antineoplastic Agents. Class Summary. Antineoplastic agents inhibit cell growth and proliferation.. Cyclophosphamide *View full ... Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998 Oct. 41 ...
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and...
Gastrointestinal Agents. Glucocorticoids. Hormones. Hormones, Hormone Substitutes, and Hormone Antagonists. Antineoplastic ... Anti-Inflammatory Agents. Antiemetics. Autonomic Agents. Peripheral Nervous System Agents. Physiological Effects of Drugs. ... Use of any investigational agents including for the treatment of multiple myeloma within 28 days or 5 half-lives (whichever is ...
WHOCC - ATC/DDD Index
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with...
Despite the benefit of adjuvant hormonal therapy (HT) on mortality among women with breast cancer (BC), many women are non- ... Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94(9): ... Hershman, D.L., Shao, T., Kushi, L.H. et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are ... Despite the benefit of adjuvant hormonal therapy (HT) on mortality among women with breast cancer (BC), many women are non- ...
Seth Kaufman's research topics | Profiles RNS
UroToday
WHOCC - ATC/DDD Index
Drug Summary
... agents are used following agents that cause clinically significant thrombocytopenia including antineoplastic agents. Tolazamide ... Higher-dose hormonal regimens may be indicated where acceptable or applicable. The alternative or additional contraceptive ... agents are used following agents that cause clinically significant thrombocytopenia including antineoplastic agents. ... agents are used following agents that cause clinically significant thrombocytopenia including antineoplastic agents. ...
Elizabeth Stephan's research topics | Palmetto Profiles
Breast feeding. Medical search. Definitions
Antineoplastic Agents, Hormonal. Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive ... Antineoplastic Agents, Phytogenic. Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic ... Receptors, EstrogenReceptor, erbB-2Receptors, ProgesteroneTamoxifenTumor Markers, BiologicalAntineoplastic Agents, Hormonal ... BRCA1Antineoplastic Agents, HormonalLymphatic MetastasisRisk FactorsNeoplasm StagingCase-Control StudiesPostmenopause ...
ClinConnect
Antineoplastic Agents, Hormonal}, {InterventionAncestorId=,D000000970, InterventionAncestorTerm=,Antineoplastic Agents ... Anti-Inflammatory Agents, InterventionBrowseBranchAbbrev=,Infl}, {InterventionBrowseBranchName=,Antineoplastic Agents ... Have been on stable anti-HIV therapy with at least two anti-HIV agents for at least 12 weeks, and you intend to remain on this ... nHave been on stable anti-HIV therapy with at least two anti-HIV agents for at least 12 weeks, and you intend to remain on this ...
Povidone. Medical search
Antineoplastic Agents, Hormonal. Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive ... Complexes of iodine and non-ionic SURFACE-ACTIVE AGENTS acting as carrier and solubilizing agent for the iodine in water. ... Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in ... LocalChlorhexidine2-PropanolIodophorsDisinfectantsSodium HypochloriteNitrilesTriazolesAromatase InhibitorsAntineoplastic Agents ...
"OncoLog Volume 51, Number 01, January 2006" by Stephanie P. Deming and Diane Witter
Search | VHL CLAP/WR-PAHO/WHO
Home
Alimentary tract and metabolism Antineoplastic and immunomodulating agents Cardiovascular & Hematopoietic System ... Systemic hormonal preparations, excl. sex hormones and insulins Respiratory system Antiinfectives for systemic use Vitamin & ... Alimentary tract and metabolism Antineoplastic and immunomodulating agents Cardiovascular & Hematopoietic System ... Alimentary tract and metabolism Antineoplastic and immunomodulating agents Cardiovascular & Hematopoietic System ...
Nilutamide: Uses, Interactions, Mechanism of Action | DrugBank Online
Nilutamide is an antineoplastic hormone used to treat prostate cancer. ... Nilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Nilutamide is a pure, ... Nilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Nilutamide is a pure, ... Labrie F: Hormonal therapy of prostate cancer. Prog Brain Res. 2010;182:321-41. doi: 10.1016/S0079-6123(10)82014-X. [Article] ...
Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent...
keywords = "Antineoplastic Agents, Hormonal/therapeutic use, B-Lymphocytes/drug effects, Comparative Genomic Hybridization, DNA ...
PRIME PubMed | Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes
Androgen AntagonistsAntineoplastic Agents, HormonalAryl Hydrocarbon HydroxylasesBiotransformationChemical and Drug Induced ... as a trapping agent. NADPH- and GSH-supplemented human liver microsomal incubations of flutamide gave rise to a novel GSH ... as a trapping agent. NADPH- and GSH-supplemented human liver microsomal incubations of flutamide gave rise to a novel GSH ... a new anti-fungal agent, in human liver microsomes. ... Antineoplastic Agents, Hormonal. *Aryl Hydrocarbon Hydroxylases ...
Gynecology Drugs Market Set to Exhibit Momentous Revenue Share at US$ 85,833.02 Mn by 2026 | ClickPress
Non-hormonal Therapy *Anti-Infective Agents. *Anti-neoplastic Agents. *Anti-inflammatory Agents ... the market has been divided into hormonal therapy and non-hormonal therapy. The non-hormonal therapy segment is likely to ... Decreasing use of hormonal products due to the risk of breast cancer has boosted the demand for non-hormonal pharmaceutical ...
Prostate Cancer Medication: Antineoplastics, GnRH Agonist, Antineoplastics, Antiandrogen, Antineoplastics, Antimicrotubular,...
Antineoplastics, Hormones. Class Summary. Estramustine is a conjugate of an alkylating agent to estradiol. As a single agent, ... Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an ... Antineoplastics, Antimicrotubular. Class Summary. Antimicrotubule chemotherapy agents such as docetaxel and cabazitaxel have ... Antifungal agents such as ketoconazole produce a response similar to that of antiandrogens. These agents provide an alternative ...
Global presence | Accord Healthcare UK
Antineoplastic and immunomodulating agents. Blood and blood forming organs. CNS. CV. Musc-skeletal. Oncology. Systemic hormonal ... Antineoplastic and immunomodulating agents. Blood and blood forming organs. CNS. Musc-skeletal. Oncology. Systemic hormonal ... Antineoplastic and immunomodulating agents. Blood and blood forming organs. CNS. Musc-skeletal. Oncology ... Systemic hormonal preparations. Systemic hormonal preparations, excl. Sex hormones and insulins. Urology ...
Djora I Soeteman, Ph.D. | Harvard Catalyst Profiles | Harvard Catalyst
Antineoplastic Agents, Hormonal. *Biomedical Research. *Brain Ischemia. *Breast Neoplasms. *Carcinoma, Intraductal, ...
malikblankenship7972 - Speech On Universal Well being Insurance coverage
Drug 1985
... hormonal mechanisms 11 Immunologic agents 12 Dermatologic agents 13 Neurologic drugs 14 Antineoplastic drugs 15 Ophthalmic ... AGENT 35420 ANTIDIABETIC AGENT 35430 ANTIEMETIC AGENT 35445 ANTIFUNGAL AGENT 35450 ANTIHISTAMINE 35455 ANTIINFECTIVE AGENT ... 08 Gastrointestinal agents 09 Metabolic and nutrient agents 10 Hormones and agents affecting ... ACIDIFYING AGENTS 54620 POTASSIUM ALKALINIZINING AGENTS 54625 POTASSIUM AMINOBENZOATE 54700 POTASSIUM GUAIACOL SULFONATE 54710 ...